Skip to main content

Table 1 Clinical details of MS patients

From: Methylation of class II transactivator gene promoter IV is not associated with susceptibility to Multiple Sclerosis

Clinical/demographic details

 

Sample Size (n)

50

Mean age of onset (years)

31.1

% Relapsing Remitting MS

68